Malegra FXT Plus

Product Overview

Malegra FXT Plus is a dual-action medication designed to simultaneously address two prevalent male sexual health conditions. This innovative tablet combines Sildenafil 100 mg and Fluoxetine 60 mg to provide a complete therapeutic approach for both erectile dysfunction and premature ejaculation, helping men achieve improved sexual performance and greater intimacy satisfaction.

Uses

Malegra FXT Plus is clinically indicated for:

1. Erectile Dysfunction (ED): Facilitates achieving and sustaining adequate penile erection through enhanced blood circulation
2. Premature Ejaculation (PE): Effectively extends intravaginal ejaculatory latency time for prolonged sexual activity

How to Use

For optimal results with Malegra FXT Plus:

1. Administer one tablet orally with 240ml (8oz) of water
2. Take 30-60 minutes prior to anticipated sexual intercourse
3. Refrain from alcohol consumption or heavy meals before administration
4. Note: Sexual arousal remains necessary for medication efficacy

Mechanism of Action

Malegra FXT Plus employs a dual pharmacological approach:

• Sildenafil: PDE5 inhibitor that enhances nitric oxide-mediated vasodilation in the corpus cavernosum
• Fluoxetine: SSRI that modulates serotonin neurotransmission to delay ejaculatory reflex

Dosage and Administration

The standard therapeutic dose is one tablet (Sildenafil 100mg/Fluoxetine 60mg) administered orally once daily, preferably 30-60 minutes before sexual activity with adequate hydration. Maximum daily dosage should not be exceeded.

Therapeutic Benefits

• Dual treatment for ED and PE in single-dose formulation
• Improved erectile quality and duration
• Enhanced ejaculatory control
• Increased sexual satisfaction
• Convenient oral administration

Adverse Effects

Common adverse reactions may include:

• Cephalalgia (headache)
• Nausea
• Vertigo
• Facial flushing
• Xerostomia (dry mouth)

These typically mild, transient effects should be reported if persistent or severe.

Precautions

Important considerations include potential drug interactions with nitrates and antihypertensives. Patients with cardiovascular, hepatic, renal, or hematologic comorbidities should obtain medical evaluation prior to use.

Contraindications

Malegra FXT Plus is contraindicated in:

• Hypersensitivity to active ingredients or excipients
• Women and pediatric populations (<18 years)
• Concurrent nitrate therapy

Cardiovascular patients and those with psychiatric history require medical supervision.

Storage Conditions

Maintain at controlled room temperature (20-25°C/68-77°F) in original packaging. Protect from moisture and light. Keep securely stored away from children and animals.

Medical Disclaimer

This information is provided for educational purposes only and does not constitute medical advice. While we strive for accuracy, this content should not replace professional medical consultation. Healthcare providers should be consulted for complete information regarding potential interactions, contraindications, and individual treatment plans. This material supports but does not replace the physician-patient relationship.